Skip to main content
. 2019 Oct 4;9:14299. doi: 10.1038/s41598-019-50528-y

Figure 5.

Figure 5

Overall survival of NSCLC patients after 5 years observation in relation to: (a) Bcl3 mRNA expression in patients of stages I to IV (cut-off point 2.09), (b) Bcl3 mRNA expression in patients of stages I and II (cut-off point 2.09), (c) Bcl3 mRNA expression in stages III & IV (cut-off point 0.43), (d) NF-κΒ2 mRNA expression in stage I patients, (e) NF-κΒ2 mRNA expression in patients without regional lymph node (LN) infiltration and (f) NF-κΒ2 mRNA expression in patients with regional LN infiltration. P values refer to univariate analysis.